Follow up of Autoantibodies in Active Tuberculosis

• Conditions: Tuberculosis

• Registration Number: NCT00551226
• Lead Sponsor: Tel-Aviv Sourasky Medical Center

Brief Summary

We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2007-10
• Study First Submitted: 2007-10-27
• Study First Submitted QC: 2007-10-29
• Last Update Submitted: 2007-10-29
• Study First Posted: 2007-10-30
• Last Update Posted: 2007-10-30
• Study Start: 2007-11
• Study Completion: 2008-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Active Tuberculosis treated

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Follow up after levels of autoantibodies	1 year

Trial Locations

Locations (1)

Tel Aviv Medical Center; 🇮🇱 Tel Aviv, Israel